Accredo Health Group, Inc
Customers
0
None disclosed
Suppliers
3
3 disclosed
Top supplier share
10%
of EXEL revenue · 3M to 2026-04-03
Top supplier by $
$61.1M
EXEL · 3M to 2026-04-03
Latest period
Apr 3, 2026
10-Q filed 2026-05-05
Suppliers 3
Companies that disclose Accredo Health Group, Inc as a major customer, as a share of their own revenue. 3 active, 0 lapsed.
| Company | % of their revenue | Est. $ from Accredo Health Group, Inc | Period | Trend | Status | Source |
|---|---|---|---|---|---|---|
| EXEL EXELIXIS, INC. |
10% | $61.1M | 3M 2026-04-03 | −1.0pp | Active | 10-Q 2026-05-05 |
Accredo Health, Incorporated 10 % 12 % Accredo Health, Incorporated 12 % 11 % 12 % Accredo Health, Incorporated 11 % 11 % 12 % 10 % | ||||||
| HRMY Harmony Biosciences Holdings, Inc. |
Named | — | 3M 2026-03-31 | +2.0pp | Active | 10-Q 2026-05-07 |
Accredo Health Group, Inc. (“Accredo”), which accounted for 41% of gross accounts receivable; Accredo Health Group, Inc. accounted for 36% of gross product revenue; and PANTHERx Specialty Pharmacy LLC accounted for 26% of gross product revenue. As of December 31, 2025, three customers accounted for 100% of gross accounts receivable, Accredo Health Group, Inc. (“Accredo”), which accounted for 45% of gross accounts receivable; | ||||||
| VRTX VERTEX PHARMACEUTICALS INC / MA |
Named | — | FY 2025-12-31 | — | Active | 10-K 2026-02-13 |
Accredo Health Group, Inc. 12 % 11 % 11 % < 10 % < 10 % | ||||||
Alerts are coming
Get an email when Accredo Health Group, Inc's disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.